Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

NCT04006457 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04006457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04006457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
July 18, 2019
Completion date
February 26, 2026
Enrollment
1,057 (actual)
Sites
144

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata